6/30/2007: Bio-inspired Machine Vision 
Topic: Bio-inspired Machine Vision
Speaker: Dr. Tai Hsu
Date: 6/30/2007, Saturday
Time: 1:00 PM to 2:00 PM
Venue:
Conference #2
NPU Administration Building
47671 Westinghouse Drive, Fremont, CA 94539

Abstract

Life started on Earth at least 3.5 billion years ago, but vision wasn't developed until ~540 million years ago. Nature itself is a giant computing machine which took many years to figure out a wonderful vision device. By studying and learning from the bio-vision, we can take advantage of the billion-year computational result to save time in designing our own machine version of it. Can an insect use just one of its two compound eyes to see things in 3D? How does it work? Why doesn’t the design require a huge brain? These are interesting questions that can now be partially answered.

Biography

Dr. Hsu's major effort has been in research and development projects. His research areas cover algorithm, artificial intelligence, chemistry, computational biology, cybernetics, robotics, and supercomputing. His work in machine 3D vision won the best paper award (European Meeting in on Cybernetics and Systems Research, 2006). His research in computational biology won the NLM award (National Library of Medicine, of National Institute of Health) in 2001. His work in quantum chemistry won the best paper award (Journal of Chinese Chemical Society, Taiwan, 1988). He was one of the main contributors to the National Science Foundation award (number 9818414, 2002) for the Linux supercomputer cluster of the Computer Science Department of Oregon State University. He was named a distinguished employee (2001) of Providian Financial Corporation for his success in automating presumably automation-impossible jobs. In the past, Dr. Hsu worked as a researcher, R&D application developer, chief engineer, programmer, system administrator, hardware test engineer, and programmer analyst in various organizations.
  |  permalink  |  related link
6/23/07: The Political Landscape 
Topic: The Political Landscape
Speaker: Mr. Donald McKenna
Date: 6/23/2007, Saturday
Time: 12:45 PM to 1:45 PM
Venue:
Main Conference Room
NPU Administration Building
47671 Westinghouse Drive, Fremont, CA 94539

Abstract

What goals should enterprises pursue?

How may they be constrained by the political environment in which they operate?

How should they respond to such constraints?

Biography

Education:
B.A.: Fordham University, Comparative Politics
M.A.: New York University, Comparative Politics & Middle East Studies

Employment:
U.S. Department of Labor, Office of Labor-Management Standards

Enforcement Program Specialist for the Pacific Region (Western US).

In my 20 years with DOL, I've carried out civil and criminal investigations relating to federal labor law, been a guest speaker at numerous joint DOL/union conferences and conducted labor studies seminars at colleges in California and Hawaii. After a six-year stint managing the Northern California-Nevada district office in the 1990's, my work is now focused on adapting computer technology to enhance OLMS' investigative and managerial effectiveness.

Northwestern Polytechnic University

I've taught several ESL, history and politics courses at NPU over the past 16 years.

Interests:
Given my fascination with exploring issues from a cross-cultural perspective, I enjoy traveling in Asia with my wife, Li Ya.
  |  permalink  |  related link
5/19/07: Have an Interesting Life 
Topic: Have an Interesting Life
Speaker: Mr. Brian Conley
Date: 5/19/2007, Saturday
Time: 12:45 PM to 1:45 PM
Venue:
Main Conference Room
NPU Administration Building
47671 Westinghouse Drive, Fremont, CA 94539

Abstract

-Life before TV

-Undergraduate life at Harvard

-Graduate school in Japan

-Memories of the Vietnam War

-Three decades at Citicorp: New York, Dallas, Hong Kong, Taiwan, San Francisco

-Cross-cultural family life

-Starting a bank

-Follow your dream

Biography

Brian Conley grew up on the US East Coast near New York City. He is a Harvard graduate with a degree in Classics and a Vietnam War veteran. He spent almost 30 years with Citicorp and started his own bank in 2005. Mr. Conley is married, has three grown children, and lives in Lafayette, CA.
  |  permalink  |  related link
5/12/07: Development of Gene Therapy 
Topic: Development of Gene Therapy
Speaker: Dr. Zhaohui Peng
Date: 5/12/2007, Saturday
Time: 12:45 PM to 1:45 PM
Venue:
Main Conference Room
NPU Administration Building
47671 Westinghouse Drive, Fremont, CA 94539

Abstract

Over the past decade, gene therapy has been broadly applied in treating life-threatening diseases, including cancer, cardiovascular disease, hereditary disease, etc. Up to Jan 2007, There are about 1260 gene therapy clinical trials going on worldwide. Recombinant Human Ad-p53 Injection, trademarked as Gendicine, developed by SiBiono GeneTech Co.,Ltd., is the world's first gene therapy medication approved by the State Food and Drug Administration of China SFDA).

To date, Gendicine has been administrated to over 5000 patients from 32 countries with distinct ethnic background. More than 50 different cancer indications were treated with significant efficacy. The most commonly observed adverse effect is self-limited fever. Based on clinical practice, Genedicine monotherapy is effective, and synergistic effects were observed when Gendicine were used in combination with conventional therapies. Moreover, accumulated clinical results indicated that Gendicine can improve patients’ quality of life and alleviate side effects caused by radiotherapy and chemotherapy. Two factors are contributed to its mechanism. One is p53 tumor suppression gene, and another Gendicine as a genetically engineered viral particle.

Many gene therapy companies have been established in the world during the past 10 years. SiBiono has established a validated production process and a comprehensive set of quality-control assays. SFDA was issued in 2003 the "Points to Consider for Human Gene Therapy and Product Quality Control" guideline.

There is no doubt that gene therapy is the science, medicine and business for the 21 century.

Biography

Zhaohui Peng, Ph.D., M.D., a well-known gene therapy expert in the world, is the founder and President of Sibiono GeneTech Co., Ltd. locked in Shenzhen, China.

Dr. Peng has been devoting himself to the research, development and commercialization of gene therapy over 17 years and has successfully made the world’s first gene therapy drug, recombinant human p53 adenoviral injection, globally trademarked name Gendicine. He worked out the points to consider for gene therapy in China, which should be the first systemic gene therapy guideline in the world.

There have been thousands of articles or media to report Dr. Peng's ground-break achievement since 2004, and he was also granted to several international awards in recognition for his great contribution to the gene therapy field and bioscience.
  |  permalink  |  related link
5/5/07: Introduction to Jump Starting Your Career with Ultimate Staffing 
Topic: Introduction to Jump Starting Your Career with Ultimate Staffing
Speaker: Ms. Savanh Prasasouk
Date: 5/5/2007, Saturday
Time: 12:45 PM to 1:45 PM
Venue:
Main Conference Room
NPU Administration Building
47671 Westinghouse Drive, Fremont, CA 94539

Abstract

· Ultimate’s Story

· Resume Tips

· Self Assessment Resources

· Interviewing Tips

· Training/Certification

Biography

Savanh Prasasouk is the Account Executive at Ultimate Staffing Services in Fremont. She has her B.S. in Business Administration with a concentration in Marketing Management from California State University of the East Bay. She has over 6 years combined work experience in Management/Sales in both Biotech and Retail Industries. She is excited to introduce you to the introductory tools and resources all provided to you from Ultimate Staffing Services to help you "jumpstart" your career while you complete your education at Northwestern Polytechnic University.
  |  permalink  |  related link

Back Next